145 related articles for article (PubMed ID: 30198866)
21. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.
Song W; Liu YY; Peng JJ; Liang HH; Chen HY; Chen JH; He WL; Xu JB; Cai SR; He YL
J Gastroenterol; 2016 Feb; 51(2):119-29. PubMed ID: 26045391
[TBL] [Abstract][Full Text] [Related]
22. LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition.
Han Y; Ye J; Wu D; Wu P; Chen Z; Chen J; Gao S; Huang J
BMC Cancer; 2014 Dec; 14():932. PubMed ID: 25496320
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance.
Zhu S; Mao J; Shao Y; Chen F; Zhu X; Xu D; Zhang X; Guo J
Tumour Biol; 2015 Sep; 36(10):8041-5. PubMed ID: 25971582
[TBL] [Abstract][Full Text] [Related]
24. H19 functions as a competing endogenous RNA to regulate human epidermal growth factor receptor expression by sequestering let‑7c in gastric cancer.
Wei Y; Liu Z; Fang J
Mol Med Rep; 2018 Feb; 17(2):2600-2606. PubMed ID: 29207111
[TBL] [Abstract][Full Text] [Related]
25. SOX2OT, a novel tumor-related long non-coding RNA.
Wang Y; Wu N; Luo X; Zhang X; Liao Q; Wang J
Biomed Pharmacother; 2020 Mar; 123():109725. PubMed ID: 31865145
[TBL] [Abstract][Full Text] [Related]
26. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
27. Allele-specific repression of Sox2 through the long non-coding RNA Sox2ot.
Messemaker TC; van Leeuwen SM; van den Berg PR; 't Jong AEJ; Palstra RJ; Hoeben RC; Semrau S; Mikkers HMM
Sci Rep; 2018 Jan; 8(1):386. PubMed ID: 29321583
[TBL] [Abstract][Full Text] [Related]
28. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
29. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
30. The Effect of MicroRNA-375 Overexpression, an Inhibitor of
Shafiee M; Aleyasin SA; Mowla SJ; Vasei M; Yazdanparast SA
Jundishapur J Microbiol; 2016 Sep; 9(9):e23464. PubMed ID: 27800139
[TBL] [Abstract][Full Text] [Related]
31. Identification of the long non‑coding RNA LET as a novel tumor suppressor in gastric cancer.
Tian J; Hu X; Gao W; Zhang J; Chen M; Zhang X; Ma J; Yuan H
Mol Med Rep; 2017 Apr; 15(4):2229-2234. PubMed ID: 28260083
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
33. Distinct gene expression patterns of
Fouani Y; Gholipour A; Oveisee M; Shahryari A; Saberi H; Mowla SJ; Malakootian M
J Genet; 2023; 102():. PubMed ID: 37017197
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
Yang Z; Guo X; Li G; Shi Y; Li L
Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
Gao J; Cao R; Mu H
Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNAs in gastric cancer carcinogenesis and metastasis.
Nasrollahzadeh-Khakiani M; Emadi-Baygi M; Schulz WA; Nikpour P
Brief Funct Genomics; 2017 May; 16(3):129-145. PubMed ID: 27122631
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG12 regulates gastric cancer progression by acting as a molecular sponge of miR‑320.
Zhang H; Lu W
Mol Med Rep; 2018 Feb; 17(2):2743-2749. PubMed ID: 29207106
[TBL] [Abstract][Full Text] [Related]
39. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis.
Shahryari A; Jazi MS; Samaei NM; Mowla SJ
Front Genet; 2015; 6():196. PubMed ID: 26136768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
